Company / Operating Cash Flow
Cencora Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$3.9B
FY2025
5-year range
$2.2B / $3.9B
FY2021-FY2025
Trend
+11.2%
vs FY2024
Sector context
#13 of 163
Health Care
What the data says
Among 163 Health Care companies, Cencora is in the top 8% for operating cash flow. Operating Cash Flow has increased for 3 consecutive years, from $2.2B in FY2022 to $3.9B in FY2025.
Based on SEC 10-K filings.
$3.9B in FY2025 with a 5-year CAGR of +11.9%. Top quartile in the Health Care sector.
Improved from $2.7B to $3.9B over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +20.6%
- 5-Year CAGR
- +11.9%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 163This company $3.9B Sector average $1.0B
▼
+270.7% above sector average
Key checks
Key Insights
- Cencora's operating cash flow has grown for 3 consecutive years.
- 5-year CAGR of +11.9%, indicating consistent growth.
- In FY2025, operating cash flow increased 11.2% year-over-year.
- Ranks #13 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.32 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.9B | +11.2% |
| FY2024 | $3.5B | +30.7% |
| FY2023 | $2.7B | +20.8% |
| FY2022 | $2.2B | -5.8% |
| FY2021 | $2.3B | +6.2% |
| FY2020 | $2.2B | -5.8% |
| FY2019 | $2.3B | +66.1% |
| FY2018 | $1.4B | -6.2% |
| FY2017 | $1.5B | -52.7% |
| FY2016 | $3.2B | -19.0% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026